Neoadjuvant Chemotherapy Plus Sequential Immune Checkpoint Inhibitor (ICI) Therapy in Locally Advanced Colon Cancer
Clinical trial NCT06368141 · RECRUITING
Trial details
- NCT number
- NCT06368141
- Sponsor
- Ruijin Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-01
- Primary completion
- 2026-02-28
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.